← Back to Clinical Trials
Recruiting NCT06983977

NCT06983977 Increasing Physical Activity Among Medical Inpatients by Digital Nudging of Patients and Staff

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06983977
Status Recruiting
Phase
Sponsor Bispebjerg Hospital
Condition Physical Activity
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2025-05-19
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Measurement of physical activityDigital nudging

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 400 participants in total. It began in 2025-05-19 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Sedentary behaviour among medical inpatients is strongly associated with hospital-associated functional decline and poses a severe threat to patients' functional capacity and independency. High human and socioeconomic costs underline the urgency to find solutions to this world-wide problem. Objective: This multicentre study, including a total of 400 patients from Copenhagen, Aalborg, Tórshavn, and Nuuk, will assess the effect of a digital intervention that aims to reduce sedentary behaviour and increase physical activity in medical inpatients. Intervention: Digital feedback and nudging regarding the patients' physical activity levels to patients and healthcare staff Design: Stepped-wedge cluster randomised multicentre trial Primary outcome: Daily average time of patients' physical activity (minutes).

Eligibility Criteria

Inclusion Criteria: * Admitted to one of the participating wards * Has understood and signed informed consent * Reads and understands Danish, Faroese, Greenlandic or English Exclusion Criteria: * Has an expected hospitalisation less than 24 hours after potential recruitment * Is not able to give informed consent to participate in the study * Has allergy towards band aid * Not able to (shortly) stand in an upright position even with maximal assistance * There are contraindications for the patient to mobilise or be physically active due to unstabilized acute medical conditions, including, but not limited to, acute aortic dissection, -myocardial infarction, -pulmonary embolism, -sepsis. * There are ethical concerns regarding the patients' participation in the study, including, but not limited to, the patient being: * In the terminal phase of life * In a crisis state regarding their disease/situation and deemed unfit for participation To ensure medically responsible inclusion of patients, the project personnel will consult and confer with the treatment responsible medical doctor, or their delegate, before including a potential participant for the trial.

Contact & Investigator

Central Contact

Durita V Gunnarsson, PhD student, MSc.

✉ durita.videroe.gunnarsson@regionh.dk

📞 +45 26472857

Principal Investigator

Christian H Dall, Associate professor, PhD

PRINCIPAL INVESTIGATOR

Bispebjerg Hospital

Frequently Asked Questions

Who can join the NCT06983977 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Physical Activity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06983977 currently recruiting?

Yes, NCT06983977 is actively recruiting participants. Contact the research team at durita.videroe.gunnarsson@regionh.dk for enrollment information.

Where is the NCT06983977 trial being conducted?

This trial is being conducted at Copenhagen, Denmark, Hobro, Denmark, Tórshavn, Faroe Islands, Nuuk, Greenland.

Who is sponsoring the NCT06983977 clinical trial?

NCT06983977 is sponsored by Bispebjerg Hospital. The principal investigator is Christian H Dall, Associate professor, PhD at Bispebjerg Hospital. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology